Brain Connections for Arm Movement After Stroke
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT04286516
- Status
- Recruiting
Conditions
- Brain Disease
- Cardiovascular Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Transcranial Magnetic Stimulation — DEVICEPaired pulse transcranial magnetic stimulation
Study Details
The purpose of this study is to use Transcranial Magnetic Stimulation (TMS) while subjects are making reaching movements in a robotic arm device in order to discover how different brain areas control movement before and after stroke and when these brain areas are most sensitive to TMS.
Key Dates
- Start date
- Jan 10, 2020
- Status verified
- May 2026
- Primary completion
- Sep 1, 2026
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 76 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Reaching with TMSAll participants enrolled in this group will receive TMS while performing reaching movements in a robotic system.
Primary Outcome Measure
Path length [ Time Frame: Immediate (within 2 s after stimulation) ]
Central Contacts
- Amy Boos(412) 648-4179
- George F Wittenberg, MD PhD(412) 360-6185
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Pittsburgh | Pennsylvania | 15240 | George F. Wittenberg, MD PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By condition
By specialty
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Improving Measurement and Treatment of Post-stroke NeglectRecruiting · VA Office of Research and Development · Pittsburgh, Pennsylvania
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona